Article Details

Imago BioSciences' Bomedemstat (IMG-7289) Shows Sustained Clinical Activity in Phase 2 Interim ...

Retrieved on: 2020-12-05 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Imago BioSciences' Bomedemstat (IMG-7289) Shows Sustained Clinical Activity in Phase 2 Interim .... View article details on hiswai:

Excerpt

Imago BioSciences, Inc., (“Imago”) a clinical-stage <b>biotechnology</b> company developing innovative treatments for myeloid diseases, today announced ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up